RxDoctor Payments Data

Monica Mauri

Internal Medicine · Coral Gables, FLNPI 1124476999

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,825 of the $4,088 with a category attached, or 69.1%. Merck accounts for 90.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $3,564 and has fallen 99.2% since, to $27 in 2025.

$4,088in general payments, 2019–2025

Across 52 payments — averaging $78.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$4K
  • Novo Nordisk$208
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$102
  • Exact Sciences$51
  • Amgen$25
  • Phadia US Inc.$22
$1,076,895in research payments, 2019–2025

Across 257 payments — averaging $4190.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$650K
  • Modernatx, Inc.$215K
  • GSK$96K
  • Merck$63K
  • Eli Lilly$26K
  • Vertex$12K
  • plus $14K from 3 others

What the payments were for

  • Travel & lodging$2,82569%
  • Food & beverage$1,26331%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,088 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Other internal medicine in Coral Gables

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →